We are planning our annual general meeting via zoom on October 13, 2021 at 7pm central time.
Please RSVP to email@example.com and the zoom login information will be sent to you.
If you would like to submit agenda items, please feel free to email them to:
firstname.lastname@example.org by September 30, 2021.
We hope you will join us.
If you have an interest in air medical transport, or hope to work in the air medical field, you should consider this program. This course will offer participants information about the following: the approach to patient transport by air,the impact of flight on...
We are planning a CAMATA Air Medical Training Program by zoom on July 5 & 6th. We are unlikely to hold another course until the fall, so if you are interested, please get your application in as early as possible in order to get your textbook and other...
The CAMATA Air Medical Training Program Level I will be held via zoom platform on May 19 & 20th, 2021 from 0830 - 1700 daily (Central Daylight Time). The course provides the following:a) Basic Air Medical information for health care providers...
COVID 19 Vaccine Information Part 2: Vaccines and their role in stopping the pandemic Aproval Process Pfizier:The Pfizer vaccine was the first to be approved in Canada and initially show to have an efficacy of 95%. Age range for administration is 16 years and above....
Hi there! I thought for this quarter I would post some information about the covid vaccine. I will do this in 3 parts
COVID 19 Vaccine Information Part 1:
The Trial Process:
Vaccines are generally tested on animals before entering into a 3-phase clinical trial process. Once all 3 phases of the trial process are complete, collected data can be submitted to Health Canada for review. See below for additional information.
Clinical trials are an essential component to the approval process of safe vaccines. Although there are approximately 150 clinical trials globally, only those that meet rigorous Canadian testing standards are suitable for distribution in Canada. Due to the pressing nature of developing a vaccine, manufacturers are using different approaches to fast tracking development. For additional information see the below link:
The below link offers an overview of 150 COVID-19 that are ongoing throughout Canada
and Internationally and is being updated weekly. Trial topics are vast and include vaccine approval and studies pertaining to the long term effects of the virus. A synopsis and link are provided for each.
The Part 2 will be related to the specific vaccines that have been approved in Canada.
We will be holding a Level One Course in Winnipeg via ZOOM on March 24 & 25, 2021. Interested participants can download the application form at https://camata.ca/wp-content/uploads/Course-application-March-2021.pdf For questions, please contact Penny Triggs at email@example.com
Given that COVID cases are on the rise again, I thought some COVID reminders would be helpful. Below is a link to STARS COVID resources, including airway management SIM videos, and infection, prevention, and control documents.
The COVID-19 pandemic has posed many challenges for the mental health and well-being of our community members. Given the potential for increased number of patients presenting to ERs for mental health services, I thought an article about management of mental health patients requiring transfer might be helpful. This article specifically looks at the use of ketamine during transports. This article is also pay for view, but I am sure could be access for free through many of our respective healthcare platforms by using the title or DOI.
“Ketamine reduces the need for intubation in patients with acute severe mental illness and agitation requiring transport to definitive care: An observational study” https://onlinelibrary.wiley.com/doi/abs/10.1111/1742-6723.12763
And finally, a short article sharing some helpful tips to keep you safe during the winter months.
Aeromedical course Level 1 in French via ZOOM February 1 & 2, 2021 https://camata.ca/wp-content/uploads/horaire-CAMATA-zoom_1-et-2-fevrier-2021.pdf